Cancer Genetics Expands Market Share In Immuno-Oncology Focused Clinical Studies
May 04, 2016 at 10:13 AM EDT
Cancer Genetics, Inc. (Nasdaq: CGIX) revealed it was actively testing and providing data for 12 Immuno-Oncology (IO) clinical trials ...
